Transcranial Magnetic Stimulation

Sep 9, 2018 by in NEUROLOGY Comments Off on Transcranial Magnetic Stimulation

Abstract More than 30 years have already passed since the seminal article of Baker et al., in which a transcranial magnetic stimulation (TMS) pulse over the motor cortex (MC) was successfully…

read more

The Birth of an Industry

Sep 9, 2018 by in NEUROLOGY Comments Off on The Birth of an Industry

Abstract This chapter is devoted to the birth and growth of the neuromodulation industry and the maturation of commercial products that accompanied the industry’s development. We will first take a…

read more

Perspectives on the Issues and Barriers to Starting a New Neuromodulation Company From New Start-Ups in Neuromodulation

Sep 9, 2018 by in NEUROLOGY Comments Off on Perspectives on the Issues and Barriers to Starting a New Neuromodulation Company From New Start-Ups in Neuromodulation

Abstract This chapter will focus on the perspectives of the leaders of several neuromodulation companies regarding the issues and barriers to starting their companies. Starting a company from an idea…

read more

Reimbursement for Neuromodulation Therapies and Technologies

Sep 9, 2018 by in NEUROLOGY Comments Off on Reimbursement for Neuromodulation Therapies and Technologies

Abstract Reimbursement strategies for health care interventions vary across the world. In the case of neuromodulation interventions, the differences, not only concern reimbursement, but also which conditions neuromodulation interventions are…

read more

Transcranial Direct Current Stimulation (tDCS)

Sep 9, 2018 by in NEUROLOGY Comments Off on Transcranial Direct Current Stimulation (tDCS)

Abstract This overview introduces the methodology, history, mechanisms, and applications of transcranial Direct Current Stimulation (tDCS). This includes tracing the historical origins of tDCS along related transcranial Electrical Stimulation (tES)…

read more

Neuromodulation : Regulatory Considerations

Sep 9, 2018 by in NEUROLOGY Comments Off on Neuromodulation : Regulatory Considerations

Abstract Researchers and companies developing new concepts in neuromodulation will, at some point, find themselves navigating the US Food and Drug Administration (FDA) regulatory programs, whether during the conduct of…

read more
Get Clinical Tree app for offline access